Kumar Krishnaswamy

Kumar Krishnaswamy

Company: Galderma

Job title: Head of Translational Medicine


Delineating the role of IL-31 in the pathophysiology of Prurigo Nodularis 12:10 pm

Shining light on the molecular and cellular characterization of PN Scientifically rationalizing the investigation of IL-31 in PN Highlighting the mechanism of action of the anti-IL-31RA drug, nemolizumab in PN using a multi-omics approachRead more

day: Day 2 AM - Track A

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.